Factors implicated in the downregulation of HLA expression include several oncogenes (e.g., HER-2/neu, RAS, and MYC) [35] also related to the transition of hormone-sensitive to castrate-resistant PCa [36]. The gene discussed is MYC; the disease is posterior cortical atrophy.